1181 related articles for article (PubMed ID: 24892633)
41. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
[TBL] [Abstract][Full Text] [Related]
42. Formulation Development and Characterization of Nanoemulsion-Based Formulation for Topical Delivery of Heparinoid.
Bakshi P; Jiang Y; Nakata T; Akaki J; Matsuoka N; Banga AK
J Pharm Sci; 2018 Nov; 107(11):2883-2890. PubMed ID: 30055224
[TBL] [Abstract][Full Text] [Related]
43. Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery.
Hua L; Weisan P; Jiayu L; Ying Z
Drug Dev Ind Pharm; 2004 Jul; 30(6):657-66. PubMed ID: 15285339
[TBL] [Abstract][Full Text] [Related]
44. Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity.
Yang Q; Liu S; Gu Y; Tang X; Wang T; Wu J; Liu J
Int J Nanomedicine; 2019; 14():3955-3966. PubMed ID: 31239665
[No Abstract] [Full Text] [Related]
45. Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery.
Ledet G; Pamujula S; Walker V; Simon S; Graves R; Mandal TK
Drug Dev Ind Pharm; 2014 Mar; 40(3):370-9. PubMed ID: 23600657
[TBL] [Abstract][Full Text] [Related]
46. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies.
Kantarci G; Ozgüney I; Karasulu HY; Arzik S; Güneri T
AAPS PharmSciTech; 2007 Nov; 8(4):E91. PubMed ID: 18181551
[TBL] [Abstract][Full Text] [Related]
47. NANOEMULSION WITH CLOTRIMAZOLE - DESIGN AND OPTIMALIZATION OF MEAN DROPLET SIZE USING MICROFLUIDIZATION TECHNIQUE.
Sosnowska K; Szymanska E; Winnicka K
Acta Pol Pharm; 2017 Mar; 74(2):519-526. PubMed ID: 29624257
[TBL] [Abstract][Full Text] [Related]
48. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
49. Boosting transdermal delivery of atorvastatin calcium via o/w nanoemulsifying system: Two-step optimization, ex vivo and in vivo evaluation.
Shaker DS; Ishak RAH; Elhuoni MA; Ghoneim AM
Int J Pharm; 2020 Mar; 578():119073. PubMed ID: 31982556
[TBL] [Abstract][Full Text] [Related]
50. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
Cirri M; Mura P; Mora PC
Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
[TBL] [Abstract][Full Text] [Related]
51. Microemulsion for topical delivery of fenoprofen calcium: in vitro and in vivo evaluation.
Farghaly DA; Aboelwafa AA; Hamza MY; Mohamed MI
J Liposome Res; 2018 Jun; 28(2):126-136. PubMed ID: 28081643
[TBL] [Abstract][Full Text] [Related]
52. Ultrasonication-assisted preparation and characterization of emulsions and emulsion gels for topical drug delivery.
Singh VK; Behera B; Pramanik K; Pal K
J Pharm Sci; 2015 Mar; 104(3):1035-44. PubMed ID: 25470664
[TBL] [Abstract][Full Text] [Related]
53. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
Zhao X; Sun Y; Li Z
Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
[TBL] [Abstract][Full Text] [Related]
54. Effect of surfactant concentration on transdermal lidocaine delivery with linker microemulsions.
Yuan JS; Yip A; Nguyen N; Chu J; Wen XY; Acosta EJ
Int J Pharm; 2010 Jun; 392(1-2):274-84. PubMed ID: 20363304
[TBL] [Abstract][Full Text] [Related]
55. Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: a preliminary study.
Shakeel F; Haq N; Al-Dhfyan A; Alanazi FK; Alsarra IA
Drug Deliv; 2015; 22(4):573-80. PubMed ID: 24350612
[TBL] [Abstract][Full Text] [Related]
56. In vitro/in vivo characterization of nanoemulsion formulation of metronidazole with improved skin targeting and anti-rosacea properties.
Yu M; Ma H; Lei M; Li N; Tan F
Eur J Pharm Biopharm; 2014 Sep; 88(1):92-103. PubMed ID: 24704200
[TBL] [Abstract][Full Text] [Related]
57. Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: In vitro, ex vivo and in vivo characterization.
Alvarado HL; Abrego G; Souto EB; Garduño-Ramirez ML; Clares B; García ML; Calpena AC
Colloids Surf B Biointerfaces; 2015 Jun; 130():40-7. PubMed ID: 25899842
[TBL] [Abstract][Full Text] [Related]
58. Development Of Saquinavir Mesylate Nanoemulsion-Loaded Transdermal Films: Two-Step Optimization Of Permeation Parameters, Characterization, And Ex Vivo And In Vivo Evaluation.
Hosny KM
Int J Nanomedicine; 2019; 14():8589-8601. PubMed ID: 31802871
[TBL] [Abstract][Full Text] [Related]
59. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
[TBL] [Abstract][Full Text] [Related]
60. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
